Literature DB >> 1589375

Hypertension in aortic valve disease and its response to valve replacement.

A Zezulka1, J Mackinnon, D G Beevers.   

Abstract

We have investigated the prevalence of hypertension and the response of blood pressure to operation in 87 patients with lone aortic valve disease who underwent aortic valve replacement. In patients with aortic stenosis alone 26% were hypertensive pre-operatively (age and sex adjusted blood pressure greater than 160 systolic and or greater than 95 mmHg diastolic) and 24% were hypertensive post-operatively. In those with aortic regurgitation alone, hypertension was present in 65% before and 57% after valve replacement using the same criterion. For combined stenosis and regurgitation, the prevalence was 54% and 62%, respectively. The post-operative increase in systolic pressure in patients with aortic stenosis occurred mainly in those with a history of left ventricular failure. In those with aortic regurgitation or combined stenosis with regurgitation, diastolic pressure rose after valve replacement resulting in a prevalence of diastolic hypertension of 44% and 35%, respectively. Blood pressure changes were not predicted by the type of valve inserted nor its size. Our data show that despite severe symptomatic aortic valve disease, systolic hypertension was common in aortic stenosis and diastolic hypertension was found in aortic regurgitation. This underlines the importance of blood pressure monitoring in patients following aortic valve replacement.

Entities:  

Mesh:

Year:  1992        PMID: 1589375      PMCID: PMC2399236          DOI: 10.1136/pgmj.68.797.180

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  20 in total

1.  The aetiology of essential hypertension. II. Scores for arterial blood pressures adjusted for differences in age and sex.

Authors:  M HAMILTON; G W PICKERING; J A F ROBERTS; G S SOWRY
Journal:  Clin Sci       Date:  1954-02       Impact factor: 6.124

2.  Quantitation of aortic valvular insufficiency by catheter thoracic aortography.

Authors:  J S LEHMAN; J J BOYLE; J N DEBBAS
Journal:  Radiology       Date:  1962-09       Impact factor: 11.105

3.  Pathogenesis of aortic stenosis and its relation to age.

Authors:  A Pomerance
Journal:  Br Heart J       Date:  1972-06

Review 4.  Advances in the hemodynamic assessment of stenotic cardiac valves.

Authors:  B A Carabello
Journal:  J Am Coll Cardiol       Date:  1987-10       Impact factor: 24.094

5.  Aortic stenosis and systemic hypertension.

Authors:  D G Beevers; P J Sloan; J Mackinnon
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-18

6.  Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis.

Authors:  J F Spann; A A Bove; G Natarajan; T Kreulen
Journal:  Circulation       Date:  1980-09       Impact factor: 29.690

7.  Factors relating to the development of hypertension after cardiopulmonary bypass.

Authors:  T J Cooper; T H Clutton-Brock; S N Jones; J Tinker; T Treasure
Journal:  Br Heart J       Date:  1985-07

8.  Increased forearm vascular reactivity in patients with hypertension after repair of coarctation.

Authors:  S S Gidding; A P Rocchini; C Moorehead; M A Schork; A Rosenthal
Journal:  Circulation       Date:  1985-03       Impact factor: 29.690

9.  Surgical pathology of pure aortic stenosis: a study of 374 cases.

Authors:  R Subramanian; L J Olson; W D Edwards
Journal:  Mayo Clin Proc       Date:  1984-10       Impact factor: 7.616

10.  Myxoid degeneration of the aortic valve and isolated severe aortic regurgitation.

Authors:  W M Allen; J M Matloff; M C Fishbein
Journal:  Am J Cardiol       Date:  1985-02-01       Impact factor: 2.778

View more
  1 in total

1.  Case of Refractory Hypertension Controlled After Aortic and Mitral Valve Replacement and Coronary Artery Bypass Grafting.

Authors:  Mohammed Siddiqui; Robert A Phillips; Michael Bursztyn; Domenic Sica; Alejandro Velasco; Eric K Judd; Tanja Dudenbostel; Steven G Lloyd; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.